Brominated Carbazole with Antibiotic Adjuvant Activity Displays Pleiotropic Effects in MRSA's Transcriptome

Area of Science:

• Microbiology
• Molecular Biology
• Pharmacology

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global health threat, with increasing hospital-acquired infections.
• Antibiotic adjuvants are crucial for overcoming bacterial resistance, particularly in conjunction with traditional antibiotics like beta-lactams.

Purpose of the Study:

• To comprehensively investigate the mechanism of action of a lead small molecule antibiotic adjuvant, compound 8.
• To determine if compound 8, when combined with oxacillin, reduces the expression of key MRSA resistance genes.
• To identify the biochemical pathways affected by this combination treatment using bioinformatic analysis.

Main Methods:

• RNA sequencing (RNA-seq) was employed to analyze global gene expression changes in MRSA upon cotreatment with oxacillin and compound 8.
• Bioinformatic tools were used for gene ontology and pathway enrichment analysis of differentially expressed genes.
• Protein-protein interaction network analysis was performed to identify potential molecular targets.

Main Results:

• Cotreatment with compound 8 and oxacillin resulted in significant upregulation (176 genes) and downregulation (233 genes) of MRSA genes.
• Enriched downregulated pathways included carbohydrate utilization (citrate cycle, phosphotransferase system) and pathways related to Staphylococcus aureus infection.
• Interaction network analysis supported Stk1 as a primary target of compound 8.

Conclusions:

• Compound 8 demonstrates a significant pleiotropic effect on the MRSA transcriptome, consistent with Stk1 kinase inhibition.
• The identified adjuvant has potential for broad therapeutic application in combating MRSA infections.
• This study highlights the potential of small molecule adjuvants as a key strategy against antibiotic-resistant bacteria.